AMIKACIN INJECTION

AMIKACIN  INJECTION 500MG

Indications:

Applicable to Pseudomonas aeruginosa and some other pseudomonas, Escherichia coli, Proteus, Klebsiella, Enterobacter, Serratia, Acinetobacter and other sensitive gram-negative bacteria and staphylococcus (methicillin-sensitive strains) caused serious infection, Such as bacteremia or septicemia, bacterial endocarditis, lower respiratory tract infection, bone and joint infection, biliary tract infection, abdominal infection, complex urinary tract infection, skin and soft tissue infection, etc.

Adverse Effects:

Patients may develop hearing loss, tinnitus or a feeling of fullness in the ears. A few patients may also have symptoms such as vertigo and unsteady gait. Hearing loss generally does not worsen after withdrawal, but some may progress to deafness after withdrawal.
This product has a certain degree of renal toxicity, patients can appear hematuria, reduced frequency of urination or reduced urine volume, blood urea nitrogen, blood creatinine value increased. Most of them are reversible, and relief can be seen immediately after withdrawal, but there are also isolated reports of renal failure.

Precautions & Warning:

If there are serious adverse reactions, please stop using this product, and seek medical treatment if the symptoms are serious.

Contra-indications:

Contraindicated in patients allergic to amikacin or other aminoglycosides.

Drug interactions:

The combination of this product with other aminoglycosides or continuous local or systemic application can increase ototoxicity, nephrotoxicity and neuromuscular blocking effect.
The combination of this product with neuromuscular blocking drugs can aggravate the neuromuscular blocking effect, resulting in muscle weakness, respiratory depression and other symptoms.

Storage instructions:

Store below 25ºC. Protect from moisture. Keep out of reach of children.